Dear Colleagues:
We are pleased to announce that the 12th Annual Symposium
on Antiviral Drug Resistance: Targets and Mechanisms will be held November 6-9, 2011, at The Hotel Hershey in Hershey, Pennsylvania.
Effective antiviral therapy is the only hope for survival or alleviation
of disease for millions of Americans and tens of millions of individuals worldwide
suffering from chronic viral infections, including those caused by HIV, HBV, HCV,
and others. In addition, there is a continuing threat of global outbreaks from influenza and other newly appearing or resurgent viruses. Despite considerable progress in the development
of effective inhibitors that target specific aspects of viral life cycles, therapeutic
efficacy has been limited by the evolution of resistant virus. This problem not
only results in the failure of therapy, but may limit the effectiveness of subsequent
therapies. Moreover, attempts to counter drug resistance lead to complex, expensive,
and toxic regimens. Antiviral drug resistance is therefore of paramount importance
in dealing with growing epidemics caused by virus infection.
The Symposium on
Antiviral Drug Resistance: Targets and Mechanisms brings together researchers studying a variety of virus systems
to exchange new information on viral targets for therapy, on antiviral drugs,
and on drug resistance. We believe that understanding the similarities
and differences in diverse viral systems will lead to new insights into the
problem of resistance in each individual virus.
The focus of the Symposium
is on specific molecular targets, their normal structure and function, their interactions
with antiviral drugs, and the evolutionary basis and specific mechanisms of viral
resistance. Organized by molecular target, the program will include invited speakers
as well as oral and poster presentations selected from submitted abstracts. The
covered topics include:
This Symposium is sponsored by the University of Pittsburgh and co-sponsored by
the HIV Drug Resistance Program of the National Cancer Institute. Through the
generous support of corporate sponsors, financial assistance is available to a
limited number of postdoctoral fellows, students, and other non-physician researchers whose abstracts are
selected for presentation but who are not in the position to support their own
participation in the Symposium. If you are interested in applying for such financial
assistance, click here
for more information.
We hope you will join us in November for what promises
to be a terrific 12th edition of this Symposium series.
|
John
W. Mellors, M.D.
Division
of Infectious Diseases
University of Pittsburgh
|
John
M. Coffin, Ph.D.
Tufts
University
(on contract to HIV Drug
Resistance Program, NCI)
|
Stephen
H. Hughes, Ph.D.
HIV
Drug Resistance Program
National Cancer Institute
|
Home
Welcome
| General
Information | Registration
| Abstract
Submission | Important
Dates
Invited
Speakers | Scientific
Program | Participation
Support | Sponsors
| Contact
|
Biology of Viral Infection